An interview with Dr. Alok Khorana
We met with Dr. Alok Khorana in Berlin during the ISTH 2017 Congress. He could not hide his enthusiasm about the...
ARCHIVE
An interview with Dr. Marc Carrier
Mark Carrier is researcher and the chair of the hemostasis and malignancies subcommittee of ISTH. During this interview...
An interview with Per Morten Sandset
Per Morten Sandset Director of Research, Innovation and Education, Senior Consultant, Professor, Southeastern Norway...
An interview with Paolo Prandoni
Paolo Prandoni Department of Cardiac, Thoracic and Vascular Sciences – Università di...
Managing antithrombotic medication in thrombocytopenia
Cancer is associated with an increased risk of venous but also arterial thrombosis1. Moreover, contemporary anticancer...
Anticoagulants for cancer survival
Max is a 61-year-old male who works as a consultant cardiologist at your same institution and who has recently been...
Exploring the relationship between hemostasis and cancer in Bergamo
From 13-15 April 2018, the most expert clinicians and basic science researchers in the field of hematology and oncology...
New perspectives for the treatment of cancer-associated thrombosis
New perspectives for the treatment of cancer-associated thrombosis Patients with cancer-associated thrombosis (CAT)...
Trial updates In thromboprophylaxis of cancer-related venous thromboembolism
The past decade has seen a large number of studies focusing on identifying cancer patients at high risk for venous...
Rational for new promising studies on occult cancer screening for patients with unprovoked venous thromboembolism
Venous thromboembolism (VTE), comprising deep vein thrombosis and pulmonary embolism, can be the first sign of an...